Novo Nordisk warned the US government not to impose pharma-specific tariffs, but instead to tax illegal importers of ...

The US’ stance on Covid-19 vaccines under HHS chief Robert F. Kennedy Jr. is coming into focus with a new approval framework, ...

Post-Hoc Live to discuss John Carroll's Endpoints 100 survey on biopharma industry sentiment, featuring Kyle LaHucik, ...

TIGIT drug collaboration. Company will wind down operations and sell assets, including EOS-984 and EOS-215 programs.

Strand Therapeutics reports early positive data for STX-001, a self-replicating mRNA cancer therapy, showing safety and ...

One of the nation’s premier cancer institutions is looking at a hefty second batch of capital to support future drugs in the ...

The Trump administration has killed two awards worth $766 million to help Moderna develop a bird flu vaccine, according to the company.

Veru's enobosarm shows safety when combined with Wegovy, Advanz-Alvotech expand biosimilar deal, Keros gets Glass Lewis support, and GeNeuro receives debt moratorium.

The FDA has rejected Savara’s application for its rare lung disease candidate over insufficient chemistry, manufacturing and ...

FDA leaders Makary, Prasad & Brenner will visit six US cities in June/July for discussions on regulatory modernization.

The CDC will no longer recommend routine Covid-19 vaccines for healthy kids and pregnant women after HHS Secretary Robert F.

Angelini will pay $50 million upfront and up to $520 million in biobucks to Grin for the ex-North America rights to ...